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NEUROENGINEERING
result in developmental neurotoxicity. Compounds testing positive 
in such a battery would then be tested in additional “second tier” 
approaches. Although the proposed list of endpoints does include 
evaluation of a number of critical neurodevelopmental processes, 
these assays are based on biochemical and morphological endpoints 
as opposed to functional endpoints. Thus, important functional 
aspects of nervous system development are not addressed including 
synaptic function, action potential generation and propagation, 
plasticity, and network formation and function.
Microelectrode array (MEA) recording techniques provide spa-
tial and temporal recordings of electrical activity from excitable 
tissues in vivo or in vitro. In vitro, MEA recordings do not disrupt cel-
lular integrity, and this makes possible repeated recordings from the 
same cell network over long periods of time (Potter and DeMarse, 
2001). When spontaneous electrical activity of primary cultures of 
cortical neurons is measured repeatedly over days in vitro (DIV), a 
clear ontogeny of activity is observed (van Pelt et al., 2005; Wagenaar 
et al., 2006). Neurons grown on MEAs faithfully recapitulate many 
functions of neurons in vivo, including spontaneous activity (spik-
ing and bursting), plasticity, and responsiveness to a wide variety 
INTRODUCTION
The potential for chemicals to harm the developing nervous system 
is a significant public concern (US EPA, 1998a; Grandjean and 
Landrigan, 2006) and a challenging problem for hazard characteri-
zation. While guidelines for determining the potential for chemicals 
to cause developmental neurotoxicity do exist (US EPA, 1998b; 
OECD, 2007), these in vivo studies are costly to conduct, require 
large numbers of animals, and take up to 2 years to complete. These 
limitations have prevented testing of large numbers of chemicals to 
determine their potential to cause developmental neurotoxicity. As 
such, efforts have begun to develop high-throughput and/or high-
content screening (HTS/HCS) approaches to assess the potential 
developmental neurotoxicity hazard associated with large numbers 
of chemicals and prioritize them for additional testing (Coecke 
et al., 2007; Lein et al., 2007). These efforts include screening assays 
for important developmental processes such as gene expression 
(Hill et al., 2008; Hogberg et al., 2009) proliferation (Breier et al., 
2008), differentiation, neurite outgrowth (Radio and Mundy, 
2008; Radio et al., 2008), and synaptogenesis (Harrill et al., 2011). 
Perturbation of these processes by environmental chemicals might 
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of  neurotransmitters and pharmacological agonists and antagonists 
(Gross et al., 1997; Potter, 2001; Marom and Shahaf, 2002; van Pelt 
et al., 2005; Pasquale et al., 2008). MEAs have also been widely uti-
lized to characterize the actions of drugs and chemicals on network 
activity in vitro, and the throughput of this technology is rapidly 
increasing (for review, see Johnstone et al., 2010). Thus, in vitro 
cultures of neurons grown on MEAs could provide a functional end-
point to assess the potential for chemicals to cause developmental 
neurotoxicity. As proof-of-principle, the ability of the protein kinase 
C (PKC) inhibitor bisindolylmaleimide (Bis-1) to affect the develop-
ment of spontaneous activity in cortical networks from rat neonates 
was assessed using MEAs. Because Bis-1 has been demonstrated to 
decrease neurite outgrowth in primary neurons and neuronal cell 
lines in vitro (Nakanishi et al., 2006; Radio et al., 2008) we hypoth-
esized that there would be a corresponding decrease in functional 
connectivity following Bis-1 exposure. The results demonstrate that 
MEAs can detect functional changes following exposure to chemi-
cals over critical periods of in vitro development and may be useful 





-tubulin antibody was purchased from Thermo 
Fisher Scientific, Inc. (Waltham, MA, USA) as part of a Cellomics® 
Neurite Outgrowth HitKit. Bisbenzamide H 33258 fluorochrome 
(Hoechst stain) was purchased from Calbiochem, Inc. (San Deigo, 
CA, USA). DyLight® 488-conjugated goat anti-mouse IgG secondary 
antibody was purchased from Millipore, Inc. (Billerica, MA, USA). 
Bisindolylmaleamide-1 (Bis-1) was obtained from Calbiochem, had 
a purity of 95%, and was dissolved in DMSO as described below.
NeURITe OUTgROwTH assay
All animal protocols were reviewed and approved by the NHEERL 
Institutional Animal Care and Use Committee and complied with 
all required animal use guidelines. Cortical cells were cultured at a 
concentration of 20,000 cells/well (6.7 × 104 cells/cm2) in CoStar® 
96-well polystyrene cell culture plates (Corning Inc., Corning, NY, 
USA) coated with poly-l-lysine. Cultures were exposed to varying 
concentrations of Bis-1 (0.1, 0.3, 1, 3, 10 μM) at 2 h after plating as 
described in Harrill et al. (2010). The final concentration of DMSO 
in control and Bis-1 treated wells was 0.1%, which had no significant 
effects on measurements of neurite outgrowth (data not shown).
At 24 h after plating cells were fixed and immunolabeled for 
β
III
-tubulin as described in Harrill et al. (2010), with modifica-
tions. Briefly, cultures were fixed in situ and immunolabeled with 
mouse anti-β
III
-tubulin primary and DyLight® 488-conjugated 
goat anti-mouse IgG secondary antibodies at dilutions of 1:800 
and 1:500, respectively, in immunocytochemical staining buffer. 
Immunolabeled cultures were sealed and stored at 4°C prior to 
image acquisition.
For automated measurements of neurite outgrowth plates were 
loaded into a Cellomics® ArrayScan® V
TI
 HCS reader high-content 
imaging system. Neurite outgrowth was measured using an opti-
mized Neuronal Profiling BioApplication protocol. Components of 
the ArrayScan® instrument and descriptions of optimization proce-
dures and neurite outgrowth algorithm workflow are as described 
previously in Harrill et al. (2010). Briefly, the ArrayScan® Neuronal 
Profiling BioApplication protocol sampled multiple unique fields 
of view within each cell culture well and acquired matched fluo-
rescent images of Hoechst labeled neuronal nuclei and β
III
-tubulin/
DyLight® 488 labeled neuronal cytoplasm for each field. Using an 
image analysis protocol optimized to untreated control wells a priori 
the BioApplication then identifies, gates and measures the morpho-
logical characteristics of fluorescently labeled neurons on a cell-by-cell 
basis. A sufficient number of fields were imaged to analyze data from 
at least 350 cells/well. Measurements from each cell were then averaged 
within each well to obtain population means for the morphologi-
cal features of interest. In the present study, well level values for the 
average number of neurites per neuron and total neurite length per 
neuron were reported. In addition, the average number of neurons per 
field (i.e., neuron density) was reported as an indicator of cell health. 
Parameters for the optimized Neuronal Profiling protocol used in the 
present study are available from the authors upon request.
Cell CUlTURe ON Meas
Briefly, cells were prepared from 0 to 1 day old Long-Evans rats. Rat 
pups were decapitated and the neocortex was carefully extracted 
from the brain and collected in Cortical buffer (127 mM NaCl, 








, 5 mM Glucose, 
59 mM Sucrose, 100 U/mL Penicillin/Streptomycin, pH 7.4). Cells 
were dissociated using 25 mg/ml trypsin. After collection in growth 
medium (Dulbecco’s Modified Eagle’s Medium w/GlutaMax 
(Invitrogen) containing 1 M HEPES, 10% heat inactivated Horse 
Serum (Invitrogen), and 100 U/mL Penicillin/Streptomycin, pH 
7.4) cells were filtered through a 100-μm nitex screen. Prior to plat-
ing of cells, MEAs (200/30ir-Ti with internal ground, Multichannel 
Systems, Reutlingen, Germany) were precoated with poly-l-lysine, 
and then on the day of culture, with laminin. MEAs were seeded 
with 2 × 105 cells in a 50-μL “drop” directly over the electrode field. 
After placing cells on the MEA, 10–15 min was allowed for cell 
adhesion prior to the addition of 1 mL culture medium. On DIV 3 
cytosine arabinoside (5 mM) was added, with a full media exchange. 
On DIV 5 cytosine arabinoside containing media was removed and 
replaced with media containing 0.1% DMSO (control MEAs) or 
5 μM Bis-1. This media remained on the MEAs for the duration 
of the experiment without any further replacement.
Mea ReCORDINgs
Spontaneous network activity in cortical neurons grown on glass 
MEAs were recorded using equipment and software from Multi 
Channel Systems (Reutlingen, Germany). During recordings, MEAs 
were placed on a temperature controlled (37°C) MCS 1060BC 
preamplifier, and covered with a fluorinated ethylene–propylene 
membrane (ALA Scientific, Westbury, NY, USA) to stabilize osmo-
larity, maintain sterility and allow for repeated recordings from the 
same chip (Potter and DeMarse, 2001). The system hardware con-
sisted of four MCS 1060BC preamplifiers that were interfaced to a 
PC via a MC_Card PCI board. MC_Rack (Version 3.6.8) software 
was used to collect spontaneous network activity data. Signals from 
the amplifier were digitized at a rate of 20 kHz and high-pass filtered 
(cutoff frequency of 200 Hz). A software-supplied spike detector 
was used to detect spontaneous events that exceeded a threshold 
of ±15 μV. All MEA recordings were conducted in culture medium 
without perfusion. Following experiments, MEA chips were re-used 
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by rinsing  thoroughly with deionized water, 1 min water sonication, 
treatment with 5% porcine pancreatin enzymes in 1× PBS buffer 
(Sigma) for 18 h, then rinsing again in deionized water and swabbing 
with a lint-free tissue to remove all cellular debris. MEAs were then 
sterilized by autoclave and 5–10 min UV light exposure.
aNalysIs Of Mea aCTIvITy
On DIV 6, 9, 13, and 20, MEAs were placed into the preampli-
fiers and allowed to equilibrate for 10 min, after which activity 
was recorded from all (59) channels for a period of 10 min. From 
each recording, the number of “Active Channels” was determined 
by counting the number of channels on that day where 5 or more 
spikes/min were observed. Burst analysis was conducted using 
Neuroexplorer (Version 3.2, NEX Technologies, Littleton, MA, 
USA). A burst was defined as a minimum of 4 spikes lasting 0.02 s 
with 0.1 s between bursts having a maximum of 0.01 s interval to 
start burst and 0.075 s to end burst (recorded in 0.02 s bins).
CyTOTOxICITy assessMeNT
Cytotoxicity in control and Bis-1 treated MEAs was assessed on DIV 
6 or 13 by propidium iodide staining of dead cells. On the day of the 
assay, media was removed and replaced with 1 ml of Lockes buffer 





d-glucose (10) HEPES (5.0), and 2 μM propidium iodide (stains 
DNA with a bright red fluorescence in cells with compromised 
plasma membranes). After a 20-min incubation period at room 
temperature, the center of each MEA was photographed with a 
digital camera attached to a Nikon TE 200 inverted epifluores-
cent microscope using a 20× objective. The number of propidium 
iodide-positive (red fluorescent) cells in each image was counted 
by an observer blind to the treatment. For each treatment, four 
images were scored from each of two different cultures, for a total 
of eight images per treatment at each timepoint.
sTaTIsTICs
Neurite outgrowth data were collected across six plates derived from 
two independent cultures. All data were normalized within plate to the 
median value of 0.1% DMSO control wells and pooled across plates 
(n = 6 well/treatment group). For the control group, the median value 
from 0.1% DMSO treated wells within each plate was normalized 
the overall mean of the median values across plates to provide error 
estimates for the control and equivalent group sizes (n = 6 wells) for 
statistical analyses. Normalized neurite outgrowth data were analyzed 
using a One-way analysis of variance (ANOVA, p < 0.05) followed by a 
Dunnett’s many-to-one mean contrast test (p < 0.01, Dunnett, 1950). 
MEA data are presented as mean ± SE and each MEA is considered 
an independent observation. Data for the fraction of MEAs that had 
active or bursting channels were analyzed using a Fisher’s exact mean 
test, while MEA spiking and bursting data were analyzed using a two-
way ANOVA with DIV and treatment (with or without Bis-1) as the 
two factors. Results were considered significant if p < 0.05. All analyses 
were performed using GraphPad Prism v5.
ResUlTs
Bis-1 is a PKC inhibitor that has been demonstrated to interfere 
with neurite outgrowth in a number of neuronal cell types. Bis-1 
produced significant concentration-dependent decreases in the 
average number of neurites per neuron and total neurite length 
per neuron (Figure 1; p < 0.05, ANOVA) following 22 h of exposure. 
Total neurite length per neuron in control cultures was 86 ± 9.6 μm. 
This measure was significantly decreased at 1 μM (84.6 ± 7.6% of 
control), 3 μM (65.9 ± 4.3% of control), and 10 μM (51.7 ± 4.4% 
of control). The average number of neurites per neuron in control 
cultures was 1.9 ± 0.15. This measure was significantly decreased at 
1 μM (85.6 ± 2.3% of control), 3 μM (69.6 ± 3.5% of control), and 
10 μM (60.8 ± 4.8% of control). The concentrations of Bis-1 which 
affected this early phase of neurite outgrowth were comparable to 
those which affected synapse development activity in longer term 
studies (Harrill et al., 2011). Based on these data, a concentration 
of 5 μM Bis-1 was selected for studies with MEAs.
Activity on MEAs exhibited a clear developmental time-course 
(Figures 2 and 3, solid lines). Activity was completely absent on 
DIV 2, began to manifest on DIV 6, and increased rapidly between 
DIV 6 and 13. The number of channels with 5 or more spikes/
min (“Active Channels”) increased to its maximum by DIV 9 and 
remained relatively constant until DIV 20 (Figure 3A, solid lines). 
A similar developmental profile was observed for the number 
of bursting channels (Figure 3B, solid lines). The total number 
of spikes and bursts observed also increased with time in cul-
ture. Two-way ANOVA indicated a significant effect of DIV on 
the number of Active Channels/MEA (p < 0.001), the number 
of bursting channels/MEA (p = 0.005), the number of spikes 
(p = 0.017), and the number of bursts (p = 0.01). Treatment of 
MEAs with 5 μM Bis-1 beginning on DIV 5 decreased spontane-
ous network activity on MEAs. The number of Active Channels/
MEA (Figure 3A, dashed lines; p = 0.007) as well as the number 
of Bursting Channels/MEA (Figure 3B, dashed lines; p = 0.0014) 
were significantly decreased by Bis-1. On DIV 6 and 9, there were 
fewer Bis-1 treated MEAs that exhibited bursting channels com-
pared to controls (Table 1) despite the fact that the fraction of 
MEAs with active channels was similar. However, the number of 
bursting channels was still significantly reduced by Bis-1 treat-
ment (p = 0.036) even if those MEAs without bursting channels 
were removed from the analysis (Figure 2C). ANOVA also indi-
cated a significant effect of Bis-1 treatment on the number of 
Active and Bursting Channels/MEA (Figures 3A, B, dashed lines), 
as well as the number of bursting channels when “non-bursting” 
MEAs were removed from the analysis (Figure 3C, dashed lines). 
There were no interactions observed between DIV and Bis-1 treat-
ment for any measure. Further, the decreases in the number of 
bursts (Figure 3D, dashed lines) and number of spikes (Figure 3E, 
dashed lines) on DIV 6 and 9 in the presence of Bis-1 were not 
statistically different from control values. An example of the spon-
taneous activity in cortical cultures, in the form of a burst of 
action potentials, is shown in Figure 4. In addition, other burst 
characteristics were not disrupted by exposure to Bis-1, including 
the percent of spikes that occurred in bursts, the burst duration, 
the mean number of spikes in a burst and the interspike interval 
(ISI) in bursts (Table 1).
To confirm that exposure to Bis-1 did not decrease the number 
of active or bursting channels via cytotoxicity following the longer 
exposures used for the MEA experiments, propidium iodide was 
used to stain dead cells on control and Bis-1 treated MEAs. Bis-1, at 
a concentration of 5 μM did not increase the number of propidium 
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network activity is decreased by a chemical that affects the mor-
phological development of cortical neurons. The present results 
demonstrate that such changes can be detected during the period 
of network development, and that assessment need not wait until 
networks have reached a stable or “mature” status. These data sup-
port that MEAs could be incorporated into screening approaches 
to detect chemicals that may cause developmental neurotoxicity 
and prioritize them for additional testing.
In the present experiments, the PKC inhibitor Bis-1 caused a 
reduction in the number of neurites/cell and the total neurite length 
in primary cultures of neocortical neurons. This is consistent with 
iodide-positive cells after 1 or 8 days of exposure (Figure 5). While 
this method does not assess all mechanisms of cell death (e.g., 
apoptosis), it does provide a demonstration that amount of cell 
death in control and Bis-1 treated cultures is similar.
DIsCUssION
These experiments demonstrate that MEAs can be utilized as a 
functional determinant of the potential developmental neurotoxic-
ity of chemicals. By following the developmental profile of activity 
of neocortical neurons cultured on MEAs in the presence or absence 
of Bis-1, these experiments clearly demonstrated that spontaneous 
Figure 1 | Bis-1 effects on neurite outgrowth. Cortical cells were plated at a 
concentration of 20,000 cells/well (6.7 × 104 cells/cm2) and exposed to varying 
concentrations of Bis-1 at 2 h post-plating. Cells were fixed and immunolabeled 
with βIII-tubulin at 24 h. Bis-1 significantly decreased the average number of 
neurites per neuron (B) and total neurite length per neuron (C) (p < 0.05, ANOVA) 
with no significant effects on neuron density (A). Symbols above the data points 
denote that the response was significantly different from control values at p < 0.01 
(**) or p < 0.001 (***) using Dunnett’s test. Representative fields showing control 
(D) and 10 μM Bis-1 treated cells (e). The experiment was repeated twice and 
data combined across 6 plates for statistical analyses (n = 6 total wells/treatment).
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the developmental profile of network activity, both across cultures 
and across laboratories, supports the utility of MEAs as a reliable 
and reproducible developmental neurotoxicity screening tool. 
Interestingly, burst characteristics including the burst duration, 
percent of spikes occurring in a burst, number of spikes/burst and 
ISI showed a less pronounced developmental profile after DIV 6 
(Table 2). These results may indicate that the most rapid period 
of burst development occurs between DIV 2 and 6, and that once 
bursting is established, it is relatively stable over the first 3 weeks 
in culture.
Treatment with the PKC inhibitor Bis-1, which decreased neu-
rite outgrowth after 24 h, decreased several different measures of 
spontaneous network activity. First, the development of activity 
in treated cultures lagged behind the control MEAs, as a smaller 
fraction of MEAs exhibited bursting activity on DIV 6 and 9 fol-
lowing Bis-1 exposure. Bis-1 also caused a significant decrease in 
the number of active channels as well as the number of channels 
on which bursting activity was observed. Although there were no 
statistically significant interactions between treatment and time, by 
DIV 20, most of these parameters were similar to the control values. 
It is not clear whether there was a “developmental lag” induced 
previously demonstrated actions of Bis-1 in both neuronal cell lines 
(Das et al., 2004) and primary neocortical cultures (Nakanishi et al., 
2006). In fact, this compound has been used as a positive “assay 
control” for development of high-throughput assays for neurite 
outgrowth due to the importance of PKC in this neurodevelop-
mental process (Radio et al., 2008). Bis-1 was used in the present 
experiments as a positive assay control compound that would alter 
neuronal network structure. Thus, the hypothesis that a chemical 
which affects the morphological development of neurons would 
also affect network function was tested.
In the present experiments, a clear ontogeny of network activity 
was observed. On DIV 2, there is no activity in the form of spikes 
or bursts. Activity begins to appear between DIV 2 and 6, and 
increases rapidly between DIV 6 and 13. This pattern of response 
is consistent with other reports of network ontogeny using MEAs 
(van Pelt et al., 2005; Wagenaar et al., 2006). This pattern was con-
sistent over the five independent cultures that comprised this data 
set, as well as across numerous other cultures (data not shown). It 
also appears to be relatively consistent across laboratories as similar 
ontogenic patterns have been identified in the published literature 
(van Pelt et al., 2005; Wagenaar et al., 2006). The consistency in 
Figure 2 | raster plots of spontaneous activity in cortical cultures on different days in vitro (DiV). Raster plots from the same cortical network on DIV 6, 9, 13, 
and 20. Each row of the raster plot represents a different electrode on the MEA, and 70 s of activity is illustrated.
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these changes in spontaneous activity. Over DIV 6–20, a similar 
fraction of the MEAs had active channels in both the treated and 
control exposures. Also, after 24 h or 8 days exposure to Bis-1, no 
significant difference in the number of propidium iodide-positive 
cells were observed on MEAs. Together, these data indicate that 
Bis-1 exposure may decrease the number of synapses formed, but 
by Bis-1 that eventually reached the same steady-state as control 
MEAs, or whether the values were closer due to the decline of the 
control values on DIV 20 (culture media was not renewed after 
DIV 5). Burst characteristics, such as burst duration, ISI and the 
percent of spikes that occur in bursts were not significantly affected 
by Bis-1 treatment. Cytotoxicity is unlikely to be responsible for 
Figure 3 | effects of Bis-1 exposure on the ontogeny of network activity. 
MEAs were prepared and treated as described in the Section “Materials and 
Methods,” and activity was measured for 10 min. Data illustrate the number of 
“Active Channels/MEA” (A), the number of Bursting Channels/MEA (B), the 
number of bursting channels on MEAs where bursting was observed (C), the 
number of bursts on bursting channels (D), and the number of spikes on 
bursting channels (e) in the absence (solid line) or presence of 5 μM Bis-1, 
beginning on DIV 5. Data are the mean ± SE of the mean (SEM) for 13–18 chips 
from five separate cultures, assessed on DIV 6, 9, 13, and 20. A subset of MEAs 
(n = 4) were assessed at DIV 2 and no activity was observed, consistent with 
previous observations. Thus, not all MEAs were tested on DIV 2 and this is 
indicated by the break in the x-axis on each graph. DIV 2 data was not included in 
the statistical analysis. Two-way analysis of variance indicated significant effects 
of DIV on the number of Active Channels/MEA (A; p < 0.001) and bursting 
channels on all MEAs (B; p = 0.005), and a significant effect of Bis-1 treatment 
on Active Channels/MEA (p = 0.007), Bursting channels on all MEAs (p = 0.0014) 
and Bursting channels on bursting MEAs (p = 0.036). There were no interactions 
between DIV and Bis-1 treatment.
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of GABA
A
 receptors by bicuculline. While the present studies did 
not attempt to evoke activity using electrical stimulation, or “chal-
lenge” spontaneous network activity with specific pharmacological 
agents, the results of Hogberg and co-workers demonstrate that such 
approaches also could be incorporated into screening approaches 
that the synapses that do form function normally. Recently, it was 
demonstrated that exposure to concentrations of Bis-1 that do not 
significantly affect neuronal density, from DIV 9–15, decreased the 
total number of synapses in primary neocortical cultures on DIV 
15 (Harrill et al., 2011). It should be noted that the density of cells 
on the MEAs is higher than the density used to determine effects 
on neurite outgrowth or synaptogenesis, and that determination 
of either one of these anatomical endpoints is difficult at the cell 
density used for the MEAs. However, both the electrophysiological 
and anatomical data are consistent in that they indicate that the 
resulting networks have fewer functional connections.
The present results provide a proof-of-concept that MEAs can be 
utilized to detect chemicals that may alter important neurodevelop-
mental processes, and may therefore be useful for screening chemicals 
for the potential to cause developmental neurotoxicity (Bal-Price 
et al., 2010; Johnstone et al., 2010). The present study examined a rela-
tively short exposure time during ontogeny of network activity and 
demonstrated a decrease in activity during this exposure. The results 
demonstrate changes in function can be detected during the period 
of network development; this may facilitate compound screening as it 
will not be necessary to wait 2–4 weeks for networks to reach maturity 
to assess potential developmental neurotoxicity. While longer-lasting 
effects were not characterized in the present study, there is evidence 
that MEAs can be utilized to detect effects following exposure as long 
as 4 weeks. Hogberg et al. (2010) demonstrated that a 4-week expo-
sure to domoic acid increased basal spike and burst rates in primary 
 cultures from rat cortex, as well as decreased the response to block 
Table 1 | Fractions of MeAs with active and bursting channels as a 
function of days in vitroa.
  DiV 6 DiV 9 DiV 13 DiV 20
MEAs with CON 14/18 18/18 15/15 17/18
active channels Bis-1 14/16 15/16 13/13 15/16
MEAs with CON 9/18 16/18 15/15 15/18
bursting channels Bis-1 4/16 8/16b 12/13 14/16
aThe numbers in the table reflect the number of chips with active or bursting 
channels in the numerator and the total number of MEAs assessed on that DIV 
in the denominator. No MEAs had active or bursting channels on DIV 2 (data 
not shown).
bStatistically significant from control (p = 0.023; Fisher’s exact test).
Figure 4 | Left Panel. Screenshot of a typical burst of action potentials 
recorded from primary cortical cultures. Middle Panel. Schematic of a burst 
indicating the measurement of burst duration and the number of spikes in a 
burst. Right Panel. Schematic of a burst that has been expanded to indicate 
the interspike interval (ISI).
Figure 5 | effect of Bis-1 exposure on cell viability. MEAs were exposed to 
5 μM Bis-1 on DIV 5, and the number of dead cells determined by staining 
with propidium iodide on DIV 6 or 13. (A) Modulation contrast 
photomicrographs of vehicle-treated neocortical cells growing on the center of 
the MEA on DIV 6 (scale bar = 100 μm). (B) Epifluorescent photomicrograph 
of propidium iodide-stained cells from the same field shown in (A). (C) 
Quantification of the number of propidium iodide-positive cells 1 day (DIV 6) or 
8 days (DIV 13) after exposure to Bis-1 (data are mean ± SE for a total of 8 
MEAs from two separate cultures).
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Table 2 | Burst characteristics are not altered by exposure to Bis-1.
  DiV 6 DiV 9 DiV 13 DiV 20
% of Spikes CON 19.3 ± 2.2 28.8 ± 3.9 30.8 ± 3.3 21.0 ± 3.5
in burstsa Bis-1 22.5 ± 9.3 30.8 ± 5.7 25.3 ± 4.8 30.9 ± 5.4
Burst CON 36.7 ± 2.6 50.9 ± 7.3 47.8 ± 3.1 34.2 ± 2.7
duration (ms) Bis-1 29.3 ± 2.7 45.7 ± 6.0 46.3 ± 6.4 50.2 ± 6.1
No. of CON 8.1 ± 0.7 11.4 ± 1.7 10.8 ± 1.0 7.6 ± 0.8
spikes/burst Bis-1 7.0 ± 0.6 10.3 ± 1.7 10.3 ± 1.8 11.8 ± 1.8
Mean interspike CON 5.4 ± 0.2 5.2 ± 0.4 5.4 ± 0.2 5.6 ± 0.2
interval in  Bis-1 5.2 ± 0.7 5.6 ± 0.2 5.8 ± 0.2 5.5 ± 0.2
bursts (ms)b 
aCalculated by dividing the number of spikes in bursts by the total number of 
spikes during the 10-min recording period, multiplied by 100 to give percentage.
bMean time between spikes occurring within a burst.
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